Analysts Remain Bullish on Gossamer Bio (GOSS) Citing Undervaluation
Gossamer Bio Inc. (NASDAQ:GOSS) is one of the best stocks under $3 to invest in. On February 4, H.C.
Gossamer Bio Inc. (GOSS)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Octagon Capital Advisors Ting Jia | 13,915,371 | $43,137,650 | -19% | 5.24% |
| 2. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 7,222,559 | $22,389,933 | +18% | 2.31% |
| 3. | 30,290,000 | $20,653,027 | +24% | 0.01% | |
| 4. | 27,860,000 | $18,664,806 | 0.61% | ||
| 5. | Siren L.L.C. Raymond Debbane | 5,208,968 | $16,147,801 | 0.48% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.92 | 26,050 | $50,016.00 | 58,050 | 2025-08-19 | Filing | |
| $0.67 | 372,000 | $250,281.60 | 5,408,073 | 2024-06-21 | Filing | |
| $0.59 | 100,000 | $59,110.00 | 480,010 | 2024-06-18 | Filing | |
| $0.60 | 25,000 | $15,050.00 | 25,000 | 2024-06-17 | Filing | |
| $0.79 | 32,000 | $25,212.80 | 32,000 | 2023-11-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.66 | 1,908 | $1,260.23 | 196,891 | 2024-06-24 | Filing | |
| $1.16 | 6,430 | $7,429.87 | 585,934 | 2024-03-27 | Filing | |
| $1.16 | 6,430 | $7,430.51 | 92,737 | 2024-03-27 | Filing | |
| $1.16 | 23,172 | $26,772.93 | 120,293 | 2024-03-27 | Filing | |
| $1.33 | 4,018 | $5,341.93 | 198,799 | 2024-03-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 18,093,034 | $56,088,405 | 2.86% | |
| 2. | 17,056,878 | $52,876,322 | 0% | |
| 3. | 12,873,209 | $39,906,948 | 0% | |
| 4. | 9,310,969 | $28,864,004 | 0% | |
| 5. | 8,055,916 | $24,973,340 | 3.83% |
News See All
11 Best Stocks Under $3 to Buy Right Now
In the stock market, stocks currently trading under $3 per share are typically small-cap stocks, defined as shares of publicly traded companies with a market capitalization between $300 million and $2...
Gossamer Bio (GOSS) Sees Strong Analyst Confidence Amid Seralutinib Progress and Upcoming PROSERA Data
By the end of Q3 2025, Gossamer Bio, Inc. (NASDAQ:GOSS) confirmed completion of enrollment in its global Phase 3 PROSERA study for pulmonary arterial hypertension, with 390 patients enrolled.
12 Best Multibagger Stocks to Buy Heading into 2026
As we head into 2026, the biggest question market participants are asking is whether the strong momentum this year can carry over into next year.
Oppenheimer Confident in Positive PROSERA Trial Readout in February 2026 for Gossamer Bio (GOSS)
Earlier on November 10, Oppenheimer analyst Andreas Argyrides raised the firm’s price target on Gossamer Bio to $12 from $9 with an Outperform rating on the shares following the company’s announcement...
20 Stocks That Will Double in 2026
On December 8, Kevin Mahn of Hennion & Walsh appeared on CNBC's 'Closing Bell Overtime' to discuss the potential for another bullish year, but with more volatility.
15 Best Biotech Penny Stocks to Invest in Right Now
Jared Holz, the healthcare strategist for Mizuho, spoke on CNBC's "Closing Bell Overtime" in July on whether the biotech industry is ready for a breakthrough.
H.C. Wainwright Asserts Buy Stance on Gossamer Bio Inc. (GOSS) on Pulmonary Arterial Hypertension Drug Prospects
Gossamer Bio Inc. (NASDAQ:GOSS) is one of the best Robinhood penny stocks to invest in. The stock has shown strong momentum, rallying by more than 100% year to date.
Piper Sandler Reiterates Buy as Seralutinib Momentum Boosts Gossamer (GOSS) Multibagger Case
Gossamer Bio Inc. (NASDAQ:GOSS) is one of the best multibagger stocks to invest in right now.
Hedge Fund Resource Center Billionaire Hedge Funds
